Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Relapsing polychondritis"
Show Display Options
Rank Status Study
1 Withdrawn Tocilizumab for Relapsing Polychondritis
Condition: Relapsing Polychondritis
Intervention: Drug: Tocilizumab
2 Completed Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab
Condition: Relapsing Polychondritis
Intervention: Drug: Tocilizumab
3 Completed Study on the Safety of Abatacept in Relapsing Polychondritis
Condition: Relapsing Polychondritis
Intervention: Drug: Abatacept

Indicates status has not been verified in more than two years